|
1
|
Bolze PA, Attia J, Massardier J, Seckl MJ,
Massuger L, van Trommel N, Niemann I, Hajri T, Schott AM and
Golfier F: EOTTD group: Formalised consensus of the European
Organisation for Treatment of Trophoblastic Diseases on management
of gestational trophoblastic diseases. Eur J Cancer. 51:1725–1731.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ryu N, Ogawa M, Matsui H, Usui H and Shozu
M: The clinical characteristics and early detection of postpartum
choriocarcinoma. Int J Gynecol Cancer. 25:926–930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ngu SF and Chan KK: Management of
chemoresistant and quiescent gestational trophoblastic disease.
Curr Obstet Gynecol Rep. 3:84–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alazzam M, Tidy J, Osborne R, Coleman R,
Hancock BW and Lawrie TA: Chemotherapy for resistant or recurrent
gestational trophoblastic neoplasia. Cochrane Database Syst Rev.
1:CD0088912016.
|
|
5
|
Rumer KK, Post MD, Larivee RS, Zink M,
Uyenishi J, Kramer A, Teoh D, Bogart K and Winn VD: Siglec-6 is
expressed in gestational trophoblastic disease and affects
proliferation, apoptosis and invasion. Endocr Relat Cancer.
19:827–840. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siu MK, Yeung MC, Zhang H, Kong DS, Ho JW,
Ngan HY, Chan DC and Cheung AN: p21-activated kinase-1 promotes
aggressive phenotype, cell proliferation, and invasion in
gestational trophoblastic disease. Am J Pathol. 176:3015–3022.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu J, Shen M, Yue Z, Yang Z, Wang M, Li
C, Xin C, Wang Y, Mei Q and Wang Z: Triptolide inhibits
colon-rectal cancer cells proliferation by induction of G1 phase
arrest through upregulation of p21. Phytomedicine. 19:756–762.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ju SM, Lee J, Kang JG, Jeong SO, Park JH,
Pae HO, Lee GS, Kim WS, Lyu YS and Jeon BH: Nardostachys chinensis
induces granulocytic differentiation with the suppression of cell
growth through p27 (Kip1) protein-related G0/G1 phase arrest in
human promyelocytic leukemic cells. Pharm Biol. 53:1002–1009. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gehen SC, Vitiello PF, Bambara RA, Keng PC
and O'Reilly MA: Downregulation of PCNA potentiates p21-mediated
growth inhibition in response to hyperoxia. Am J Physiol Lung Cell
Mol Physiol. 292:L716–L724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Faouzi M, Kischel P, Hague F, Ahidouch A,
Benzerdjeb N, Sevestre H, Penner R and Ouadid-Ahidouch H: ORAI3
silencing alters cell proliferation and cell cycle progression via
c-myc pathway in breast cancer cells. Biochim Biophys Acta.
1833:752–760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang F, Kong DS, Zhang ZL, Lei N, Zhu XJ,
Zhang XP, Chen L, Lu Y and Zheng SZ: Tetramethylpyrazine induces
G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and
caspase-dependent apoptosis through modulating ERK/p53 signaling in
hepatic stellate cells in vitro. Apoptosis. 18:135–149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu E, Li J, Shi S, Wang X, Liang T, Wu B
and Li Q: Sustained ERK activation-mediated proliferation
inhibition of farrerol on human gastric carcinoma cell line by
G0/G1-phase cell-cycle arrest. Eur J Cancer Prev. 25:490–499. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao HB, Tang CL, Hou YL, Xue LR, Li MQ,
Du MR and Li DJ: CXCL12/CXCR4 axis triggers the activation of EGF
receptor and ERK signaling pathway in CsA-induced proliferation of
human trophoblast cells. PLoS One. 7:e383752012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie Y, Cui D, Sui L, Xu Y, Zhang N, Ma Y,
Li Y and Kong Y: Induction of forkhead box M1 (FoxM1) by EGF
through ERK signaling pathway promotes trophoblast cell invasion.
Cell Tissue Res. 362:421–430. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liggins J, Mulligan A, Runswick S and
Bingham SA: Daidzein and genistein content of cereals. Eur J Clin
Nutr. 56:961–966. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu A, Bray TM, Helferich WG, Doerge DR
and Ho E: Differential effects of whole soy extract and soy
isoflavones on apoptosis in prostate cancer cells. Exp Biol Med
(Maywood). 235:90–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Z, Zhou R, Kong Y, Wang J, Xia W, Guo
J, Liu J, Sun H, Liu K, Yang J, et al: S-equol, a secondary
metabolite of natural anticancer isoflavone daidzein, inhibits
prostate cancer growth in vitro and in vivo, Though activating the
Akt/FOXO3a pathway. Curr Cancer Drug Targets. 16:455–465. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Charalambous C, Pitta CA and Constantinou
AI: Equol enhances tamoxifen's anti-tumor activity by induction of
caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC
Cancer. 13:2382013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi EJ and Kim GH: Daidzein causes cell
cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7
and MDA-MB-453 cells. Phytomedicine. 15:683–690. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo JM, Xiao BX, Liu DH, Grant M, Zhang S,
Lai YF, Guo YB and Liu Q: Biphasic effect of daidzein on cell
growth of human colon cancer cells. Food Chem Toxicol.
42:1641–1646. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iwashita K, Kobori M, Yamaki K and
Tsushida T: Flavonoids inhibit cell growth and induce apoptosis in
B16 melanoma 4A5 cells. Biosci Biotechnol Biochem. 64:1813–1820.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park HJ, Jeon YK, You DH and Nam MJ:
Daidzein causes cytochrome c-mediated apoptosis via the
Bcl-2 family in human hepatic cancer cells. Food Chem Toxicol.
60:542–549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang S, Hu J, Meng Q, Dong X, Wang K, Qi
Y, Chu C, Zhang X and Hou L: Daidzein induced apoptosis via
down-regulation of Bcl-2/Bax and triggering of the mitochondrial
pathway in BGC-823 cells. Cell Biochem Biophys. 65:197–202. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo JM, Kang GZ, Xiao BX, Liu DH and Zhang
S: Effect of daidzein on cell growth, cell cycle, and telomerase
activity of human cervical cancer in vitro. Int J Gynecol Cancer.
14:882–888. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeschke U, Briese V, Richter DU, Bruer G,
Plessow D, Waldschläger J, Mylonas I and Friese K: Effects of
phytoestrogens genistein and daidzein on production of human
chorionic gonadotropin in term trophoblast cells in vitro. Gynecolo
Endocrinol. 21:180–184. 2005. View Article : Google Scholar
|
|
26
|
Bielecki A, Roberts J, Mehta R and Raju J:
Estrogen receptor-β mediates the inhibition of DLD-1 human colon
adenocarcinoma cells by soy isoflavones. Nutr Cancer. 63:139–150.
2011.PubMed/NCBI
|
|
27
|
He Y, Wu X, Cao Y, Hou Y, Chen H, Wu L, Lu
L, Zhu W and Gu Y: Daidzein exerts anti-tumor activity against
bladder cancer cells via inhibition of FGFR3 pathway. Neoplasma.
63:523–531. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lim TG, Kim JE, Lee SY, Park JS, Yeom MH,
Chen H, Bode AM, Dong Z and Lee KW: The daidzein metabolite,
6,7,4′-Trihydroxyisoflavone, is a novel inhibitor of PKCα in
suppressing solar UV-induced matrix metalloproteinase 1. Int J Mol
Sci. 15:21419–21432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kang NJ, Lee KW, Rogozin EA, Cho YY, Heo
YS, Bode AM, Lee HJ and Dong Z: Equol, a metabolite of the soybean
isoflavone daidzein, inhibits neoplastic cell transformation by
targeting the MEK/ERK/p90RSK/activator protein-1 pathway. J Biol
Chem. 282:32856–32866. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seckl MJ, Sebire NJ and Berkowitz RS:
Gestational trophoblastic disease. Lancet. 376:717–729. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bao C, Namgung H, Lee J, Park HC, Ko J,
Moon H, Ko HW and Lee HJ: Daidzein suppresses tumor necrosis
factor-α induced migration and invasion by inhibiting hedgehog/Gli1
signaling in human breast cancer cells. J Agric Food Chem.
62:3759–3767. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi EJ and Kim GH: Antiproliferative
activity of daidzein and genistein may be related to ERα/c-erbB-2
expression in human breast cancer cells. Mol Med Rep. 7:781–784.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Suzuki N, Laxmi Santosh YR, Okamoto
Y and Shibutani S: Anti-breast cancer potential of daidzein in
rodents. Life Sci. 91:415–419. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Casagrande F and Darbon JM: Effects of
structurally related flavonoids on cell cycle progression of human
melanoma cells: Regulation of cyclin-dependent kinases CDK2 and
CDK1. Biochem Pharmacol. 61:1205–1215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Higashi K and Ogawara H: Daidzein inhibits
insulin- or insulin-like growth factor-1-mediated signaling in cell
cycle progression of Swiss 3T3 cells. Biochim Biophys Acta.
1221:29–35. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ito T, Yamada S, Tanaka C, Ito S, Murai T,
Kobayashi D, Fujii T, Nakayama G, Sugimoto H, Koike M, et al:
Overexpression of L1CAM is associated with tumor progression and
prognosis via ERK signaling in gastric cancer. Ann Surg Oncol.
21:560–568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sadaria MR, Yu JA, Meng X, Fullerton DA,
Reece TB and Weyant MJ: Secretory phospholipase A2 mediates human
esophageal adenocarcinoma cell growth and proliferation via ERK 1/2
pathway. Anticancer Res. 33:1337–1342. 2013.PubMed/NCBI
|
|
38
|
Han S, Li Z, Master LM, Master ZW and Wu
A: Exogenous IGFBP-2 promotes proliferation, invasion, and
chemoresistance to temozolomide in glioma cells via the integrin
β1-ERK pathway. Br J Cancer. 111:1400–1409. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singh-Gupta V, Zhang H, Yunker CK, Ahmad
Z, Zwier D, Sarkar FH and Hillman GG: Daidzein effect on hormone
refractory prostate cancer in vitro and in vivo compared to
genistein and soy extract: Potentiation of radiotherapy. Pharm Res.
27:1115–1127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee DE, Lee KW, Jung SK, Lee EJ, Hwang JA,
Lim TG, Kim BY, Bode AM, Lee HJ and Dong Z:
6,7,4′-trihydroxyisoflavone inhibits HCT-116 human colon cancer
cell proliferation by targeting CDK1 and CDK2. Carcinogenesis.
32:629–635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Somjen D, Grafi-Cohen M, Katzburg S,
Weisinger G, Izkhakov E, Nevo N, Sharon O, Kraiem Z, Kohen F and
Stern N: Anti-thyroid cancer properties of a novel isoflavone
derivative, 7-(O)-carboxymethyl daidzein conjugated to
N-t-Boc-hexylenediamine in vitro and in vivo. J Steroid Biochem Mol
Biol. 126:95–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
